Spanish studies claim that an active form of vitamin D may reduce the risk of severity of COVID-19

A new study conducted in Spain has shown that high doses of calcidiol, the active form of vitamin D, can significantly reduce the risk of ICU treatment of COVID-19 patients.

This conclusion has come to light as scientists are searching for an antiviral inexpensive drug that can treat patients suffering from severe COVID-19 infection.

the study

The Spanish study published in ScienceDirect was conducted on 50–76 patients hospitalized with COVID-19. These patients were treated with calcifediol and only one of these patients required ICU hospitalization. The remaining patients were discharged without any complication.

Of those who did not receive the drug, some were admitted to the ICU and two died. Marta Antrenus stated, “Our pilot study showed that administration of a high dose of calcidiol or 25-hydroxyvitamin D is the main metabolite of the vitamin D endocrine system, which has led to the need for ICU treatment of hospitalized patients due to Kovid-19. Significantly reduced, ”said Marta Entrenas. The lead author of the study report Castillo of Renasofia University Hospital in Cordoba.

Calcifediol proved to be able to reduce the risk of severe COVID infection, although more tests are needed on larger groups to establish a definitive answer.